Chemotherapy Plus IM-862 in Treating Patients With Metastatic Colorectal Cancer

Part of paid clinical trials in Los Angeles, California.

Sponsor
University of Southern California
Study ID
NCT00006037
Phase
PHASE2
Status
Terminated

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. IM-862 may stop the growth of colorectal cancer by stopping blood flow to the tumor. It is not yet known if chemotherapy is more effective with or without IM-862 in treating colorectal cancer. PURPOSE: Randomized phase II trial to study the effectiveness of chemotherapy plus IM-862 in treating patients who have metastatic colorectal cancer.

Key Dates

Start date
Nov 30, 1999
Status verified
May 2014
Primary completion
Nov 30, 2001
Completion
Nov 30, 2001

Study Design

Enrollment
18 participants (actual)
Primary purpose
TREATMENT

Locations (1)

FacilityCityStateZIPSite coordinators
USC/Norris Comprehensive Cancer Center and HospitalLos AngelesCalifornia90033-0804-

Find similar trials in Los Angeles, CA

By condition
Colorectal cancer
By specialty
OncologyGI oncology
By research site
USC/Norris Comprehensive Cancer Center and Hospital· Los Angeles, CA

Related Studies